• This record comes from PubMed

Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterations

. 2024 Jul 18 ; 148 (1) : 7. [epub] 20240718

Language English Country Germany Media electronic

Document type Letter, Research Support, Non-U.S. Gov't

Grant support
2021_EKMS.15 Else Kröner-Fresenius-Stiftung

Links

PubMed 39026106
PubMed Central PMC11258072
DOI 10.1007/s00401-024-02766-2
PII: 10.1007/s00401-024-02766-2
Knihovny.cz E-resources

Berlin Institute of Health Charité Universitätsmedizin Berlin Berlin Germany

Clinical Cooperation Unit Neurooncology German Consortium for Translational Cancer Research Heidelberg Germany

Clinical Cooperation Unit Neuropathology German Consortium for Translational Cancer Research Heidelberg Germany

Departamento de Neuropatología y Biología Molecular Instituto de Investigaciones Neurológicas Dr Raúl Carrea Buenos Aires Argentina

Department of Clinical Research University of Southern Denmark Odense Denmark

Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology Queen Square London UK

Department of Neurology and Neurooncology Program National Center for Tumor Diseases Heidelberg University Hospital Heidelberg Germany

Department of Neuropathology AP HP Pitié Salpêtrière Hospital 75013 Paris France

Department of Neuropathology Charité Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin Berlin Germany

Department of Neuropathology Institute of Pathology University Hospital Heidelberg Heidelberg Germany

Department of Neuroradiology AP HP Pitié Salpêtrière Hospital 75013 Paris France

Department of Neurosurgery AP HP Pitié Salpêtrière Hospital 75013 Paris France

Department of Neurosurgery Heidelberg University Hospital Heidelberg Germany

Department of Pathology Amsterdam University Medical Centers Location VUmc and Brain Tumor Center Amsterdam Amsterdam The Netherlands

Department of Pathology and Neuropathology APHM CHU Timone Marseille France

Department of Pathology Odense University Hospital Odense Denmark

Department of Pediatric Haematology and Oncology 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Department of Pediatric Hematology and Oncology University Medical Center Hamburg Eppendorf Hamburg Germany

Department of Pediatric Oncology Hematology Immunology and Pulmonology University Hospital Heidelberg Heidelberg Germany

Division of Neuropathology National Hospital for Neurology and Neurosurgery University College London Hospitals NHS Foundation Trust Queen Square London UK

Division of Pediatric Glioma Research German Cancer Research Center Heidelberg Germany

Division of Pediatric Neurooncology German Consortium for Translational Cancer Research Heidelberg Germany

Frankfurt Cancer Institute Frankfurt am Main Germany

German Cancer Consortium Heidelberg Germany

Hopp Children's Cancer Center Heidelberg Heidelberg Germany

Institute of Neurology University Hospital Frankfurt Goethe University Frankfurt am Main Germany

Institute of Neuropathology Justus Liebig University Giessen Giessen Germany

Institute of Neuropathology University Medical Center Hamburg Eppendorf Hamburg Germany

Institute of Neurophysiopathol CNRS INP Aix Marseille University Marseille France

Laboratory of Pathology Center for Cancer Research National Cancer Institute National Institutes of Health Bethesda MD USA

National Center for Tumor Diseases NCT Heidelberg a partnership between DKFZ and Heidelberg University Hospital Heidelberg Germany

Prague Brain Tumor Research Group 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands

Research Institute Children's Cancer Center Hamburg Hamburg Germany

Sorbonne Université Inserm CNRS UMR S 1127 Paris Brain Institute ICM 75013 Paris France

See more in PubMed

Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555:469–474. doi: 10.1038/nature26000. PubMed DOI PMC

Consortium G Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium. Neuro Oncol. 2018;20:873–884. doi: 10.1093/neuonc/noy020. PubMed DOI PMC

Deng MY, Sill M, Sturm D, Stichel D, Witt H, Ecker J, Wittmann A, Schittenhelm J, Ebinger M, Schuhmann MU, et al. Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC)—a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14. Neuropathol Appl Neurobiol. 2020;46:422–430. doi: 10.1111/nan.12590. PubMed DOI

Fangusaro J, Jones DT, Packer RJ, Gutmann DH, Milde T, Witt O, Mueller S, Fisher MJ, Hansford JR, Tabori U, et al. Pediatric low-grade glioma: state-of-the-art and ongoing challenges. Neuro Oncol. 2024;26:25–37. doi: 10.1093/neuonc/noad195. PubMed DOI PMC

Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23:1231–1251. doi: 10.1093/neuonc/noab106. PubMed DOI PMC

Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015–2019. Neuro Oncol. 2022;24:v1–v95. doi: 10.1093/neuonc/noac202. PubMed DOI PMC

Pfister SM, Reyes-Mugica M, Chan JKC, Hasle H, Lazar AJ, Rossi S, Ferrari A, Jarzembowski JA, Pritchard-Jones K, Hill DA, et al. A summary of the inaugural WHO classification of pediatric tumors: transitioning from the optical into the molecular era. Cancer Discov. 2022;12:331–355. doi: 10.1158/2159-8290.CD-21-1094. PubMed DOI PMC

Reinhardt A, Stichel D, Schrimpf D, Sahm F, Korshunov A, Reuss DE, Koelsche C, Huang K, Wefers AK, Hovestadt V, et al. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Acta Neuropathol. 2018;136:273–291. doi: 10.1007/s00401-018-1837-8. PubMed DOI

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...